Is abnormal polymorphonuclear leukocyte function in end-stage renal failure associated with increased incidence of CAPD peritonitis ?
- Author
- PORTER, C. J1 ; DASGUPTA, I1 ; BURDEN, R. P1
[1] Renal Unit, Nottingham City Hospital NHS Trust, Nottingham, United Kingdom - Conference title
- European Peritoneal Dialysis Meeting
- Conference name
- European Peritoneal Dialysis Meeting (3 ; Edinburgh, Scotland 1998-04-05)
- Source
Peritoneal dialysis international. 1998, Vol 18, Num 1, pp 75-77 ; ref : 7 ref
- ISSN
- 0896-8608
- Scientific domain
- Urology, nephrology
- Publisher
- Multimed, Milton, ON
- Publication country
- Canada
- Document type
- Conference Paper
- Language
- English
- Keyword (fr)
- Adulte Ambulatoire Complication Continu Dialyse péritonéale Epidémiologie Granulocyte Incidence Indice gravité Insuffisance rénale Leucocyte Pathogénie Péritonite Stade terminal Trouble fonctionnel Abdomen pathologie Appareil urinaire pathologie Epuration extrarénale Homme Rein pathologie
- Keyword (en)
- Adult Ambulatory Complication Continuous Peritoneal dialysis Epidemiology Granulocyte Incidence Severity score Renal failure Leukocyte Pathogenesis Peritonitis Terminal stage Dysfunction Abdominal disease Urinary system disease Extrarenal dialysis Human Kidney disease
- Keyword (es)
- Adulto Ambulatorio Complicación Contínuo Diálisis peritoneal Epidemiología Granulocito Incidencia Indicio gravedad Insuficiencia renal Leucocito Patogenia Peritonitis Estadio terminal Trastorno funcional Abdomen patología Aparato urinario patología Depuración extrarrenal Hombre Riñón patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B27 Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy / 002B27B Intensive care medicine / 002B27B03 Emergency and intensive care: renal failure. Dialysis management
- Discipline
- Anaesthesia. Reanimation. Transfusion. Cell therapy and gene therapy
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 2176264
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1177/089686089801800110 
https://dx.doi.org/10.1177/089686089801800110
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1177\/089686089801800110\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:133:\"Is abnormal polymorphonuclear leukocyte function in end-stage renal failure associated with increased incidence of CAPD peritonitis ?\";s:9:\"\u0000*\u0000jtitle\";s:33:\"Peritoneal dialysis international\";s:9:\"\u0000*\u0000stitle\";s:16:\"Perit. dial. int\";s:7:\"\u0000*\u0000date\";s:4:\"1998\";s:9:\"\u0000*\u0000volume\";s:2:\"18\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"75\";s:8:\"\u0000*\u0000epage\";s:2:\"77\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0896-8608\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"PORTER\";s:10:\"\u0000*\u0000aufirst\";s:4:\"C. J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:11:\"DASGUPTA, I\";i:1;s:12:\"BURDEN, R. P\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:36:\"European Peritoneal Dialysis Meeting\";s:8:\"\u0000*\u0000title\";s:133:\"Is abnormal polymorphonuclear leukocyte function in end-stage renal failure associated with increased incidence of CAPD peritonitis ?\";s:8:\"\u0000*\u0000place\";s:10:\"Milton, ON\";s:6:\"\u0000*\u0000pub\";s:8:\"Multimed\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1177\/089686089801800110\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:133:\"Is abnormal polymorphonuclear leukocyte function in end-stage renal failure associated with increased incidence of CAPD peritonitis ?\";s:9:\"\u0000*\u0000jtitle\";s:33:\"Peritoneal dialysis international\";s:9:\"\u0000*\u0000stitle\";s:16:\"Perit. dial. int\";s:7:\"\u0000*\u0000date\";s:4:\"1998\";s:9:\"\u0000*\u0000volume\";s:2:\"18\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"75\";s:8:\"\u0000*\u0000epage\";s:2:\"77\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0896-8608\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"PORTER\";s:10:\"\u0000*\u0000aufirst\";s:4:\"C. J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:11:\"DASGUPTA, I\";i:1;s:12:\"BURDEN, R. P\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:36:\"European Peritoneal Dialysis Meeting\";s:8:\"\u0000*\u0000title\";s:133:\"Is abnormal polymorphonuclear leukocyte function in end-stage renal failure associated with increased incidence of CAPD peritonitis ?\";s:8:\"\u0000*\u0000place\";s:10:\"Milton, ON\";s:6:\"\u0000*\u0000pub\";s:8:\"Multimed\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:26:\"10.1177\/089686089801800110\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1177\/089686089801800110\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:133:\"Is abnormal polymorphonuclear leukocyte function in end-stage renal failure associated with increased incidence of CAPD peritonitis ?\";s:9:\"\u0000*\u0000jtitle\";s:33:\"Peritoneal dialysis international\";s:9:\"\u0000*\u0000stitle\";s:16:\"Perit. dial. int\";s:7:\"\u0000*\u0000date\";s:4:\"1998\";s:9:\"\u0000*\u0000volume\";s:2:\"18\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"75\";s:8:\"\u0000*\u0000epage\";s:2:\"77\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0896-8608\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"PORTER\";s:10:\"\u0000*\u0000aufirst\";s:4:\"C. J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:11:\"DASGUPTA, I\";i:1;s:12:\"BURDEN, R. P\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:36:\"European Peritoneal Dialysis Meeting\";s:8:\"\u0000*\u0000title\";s:133:\"Is abnormal polymorphonuclear leukocyte function in end-stage renal failure associated with increased incidence of CAPD peritonitis ?\";s:8:\"\u0000*\u0000place\";s:10:\"Milton, ON\";s:6:\"\u0000*\u0000pub\";s:8:\"Multimed\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1177\/089686089801800110\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:133:\"Is abnormal polymorphonuclear leukocyte function in end-stage renal failure associated with increased incidence of CAPD peritonitis ?\";s:9:\"\u0000*\u0000jtitle\";s:33:\"Peritoneal dialysis international\";s:9:\"\u0000*\u0000stitle\";s:16:\"Perit. dial. int\";s:7:\"\u0000*\u0000date\";s:4:\"1998\";s:9:\"\u0000*\u0000volume\";s:2:\"18\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"75\";s:8:\"\u0000*\u0000epage\";s:2:\"77\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0896-8608\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"PORTER\";s:10:\"\u0000*\u0000aufirst\";s:4:\"C. J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:11:\"DASGUPTA, I\";i:1;s:12:\"BURDEN, R. P\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:36:\"European Peritoneal Dialysis Meeting\";s:8:\"\u0000*\u0000title\";s:133:\"Is abnormal polymorphonuclear leukocyte function in end-stage renal failure associated with increased incidence of CAPD peritonitis ?\";s:8:\"\u0000*\u0000place\";s:10:\"Milton, ON\";s:6:\"\u0000*\u0000pub\";s:8:\"Multimed\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1177\/089686089801800110\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:133:\"Is abnormal polymorphonuclear leukocyte function in end-stage renal failure associated with increased incidence of CAPD peritonitis ?\";s:9:\"\u0000*\u0000jtitle\";s:33:\"Peritoneal dialysis international\";s:9:\"\u0000*\u0000stitle\";s:16:\"Perit. dial. int\";s:7:\"\u0000*\u0000date\";s:4:\"1998\";s:9:\"\u0000*\u0000volume\";s:2:\"18\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"75\";s:8:\"\u0000*\u0000epage\";s:2:\"77\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0896-8608\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"PORTER\";s:10:\"\u0000*\u0000aufirst\";s:4:\"C. J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:11:\"DASGUPTA, I\";i:1;s:12:\"BURDEN, R. P\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:36:\"European Peritoneal Dialysis Meeting\";s:8:\"\u0000*\u0000title\";s:133:\"Is abnormal polymorphonuclear leukocyte function in end-stage renal failure associated with increased incidence of CAPD peritonitis ?\";s:8:\"\u0000*\u0000place\";s:10:\"Milton, ON\";s:6:\"\u0000*\u0000pub\";s:8:\"Multimed\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
